CSI Market
Sign In | Register

Plx Pharma Inc (PLXP) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PLXP Annual Cash Flow →
From Plx Pharma Inc through Sep 30 2021, changes in Sep 30 2022's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-31.14
Depreciation & amortization0.09
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-0.72
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation3.25
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-12.28
Expenses Allocated To Warrant Liability-
Increase Decrease In Contract Manufacturing Deposits-
Increase Decrease In Interest Payable Net Excluding Related Parties-
Impairment Of Intangible Assets Excluding Goodwill-
Increase Decrease In Operating Lease Right Of Use Asset0.07
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.50
Increase (Decrease) in Accounts Payable and Accrued Liabilities-5.53
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.08
Other Working Capital-0.08
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.05
Discontinued operations0.00
Net Cash flow from Operating Activities-45.97
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-69.39
Proceeds From Convertible Debt Excluding Related Parties-
Proceeds From Convertible Debt Related Parties-
Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs-
Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs-
Proceeds From Issuance Of Common Stock Net Issuance Costs2.42
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations69.39
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.42
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-45.97
Total Cash Flow-43.56
4 historic quarters locked

Sign in to unlock the full Plx Pharma Inc cash flow history.

Sign In Create Free Account

About Plx Pharma Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-22-026958

Figures are derived from filed reports and may be restated. Historical data is subject to revision.